Literature DB >> 10775031

Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.

A Inoue1, H Wada, M Takagi, M Yamamuro, K Mukai, T Nakasaki, M Shimura, K Hiyoyama, H Deguchi, E C Gabazza, Y Mori, M Nishikawa, K Deguchi, H Shiku.   

Abstract

Before hemodialysis (HD), plasma levels of tissue factor (TF), free-TF pathway inhibitor (TFPI) and thrombomodulin (TM) were significantly higher in patients with HD than in healthy volunteers. Plasma levels of (T-F) TFPI and plasmin plasmin inhibitor complex (PPIC) were significantly higher in patients with HD than in healthy volunteers. During HD, plasma levels of TF and (T-F) TFPI were not significantly increased, but plasma levels of total TFPI and free TFPI at 1 hour after and at the end of HD were significantly increased, compared with levels before start of HD. Plasma level of PPIC 1 hour after start of HD was significantly higher than before start of HD, and plasma levels of thrombin antithrombin complex (TAT), PPIC, D-dimer, TM, and protein C (PC) at the end of HD were significantly higher than before start of HD. In patients with thrombosis complications, plasma TF levels were significantly higher than in patients without thrombotic complications during HD. Plasma levels of PC were significantly lower in patients with thrombotic complications than in patients without thrombotic complications. There was no significant difference between both groups during HD in hemostatic parameters, with the exception of TF and PC. Hemostatic abnormalities existed in patients with HD; especially, increased TF and decreased PC might cause thrombotic complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775031     DOI: 10.1177/107602960000600210

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

2.  The effects of citrate dialysate in hemodialysis on polymorphonuclear elastase interaction with tissue factor and its inhibitor.

Authors:  Jiameng Li; Si Sun; Mei Han; Liya Wang; Ruoxi Liao; Yuqin Xiong; Yupei Li; Heng Jiang; Zheng Qin; Anil Maharjan; Mario Cozzolino; Alexander Zarbock; Baihai Su
Journal:  Ann Transl Med       Date:  2019-08

3.  Protein C and protein S deficiencies may be related to survival among hemodialysis patients.

Authors:  Mayuri Ichinose; Naru Sasagawa; Tetsuo Chiba; Katsuhide Toyama; Yuzo Kayamori; Dongchon Kang
Journal:  BMC Nephrol       Date:  2019-05-28       Impact factor: 2.388

4.  Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.

Authors:  James A Milburn; Isobel Ford; Nicola J Mutch; Nicholas Fluck; Julie Brittenden
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.